Artificial Intelligence (Ai) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025

世界の医療診断における人工知能(Ai)市場予測:コンポーネント別、用途別、エンドユーザー別

◆タイトル:Artificial Intelligence (Ai) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025
◆商品コード:HIT7875
◆調査・発行会社:MarketsandMarkets
◆発行日:2021年4月15日
◆ページ数:167
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界の医療診断における人工知能(Ai)市場規模が2020年505百万ドルから2025年3,868百万ドルまで、年平均50.2%成長すると予測しています。本調査レポートでは、医療診断における人工知能(Ai)の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、コンポーネント別(ソフトウェア、サービス)分析、用途別(In Vivo診断、放射線、心臓病、神経、産科/婦人科)分析、エンドユーザー別(病院、画像診断センター、診断研究所、その他)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の医療診断における人工知能(Ai)市場規模:コンポーネント別(ソフトウェア、サービス)
・世界の医療診断における人工知能(Ai)市場規模:用途別(In Vivo診断、放射線、心臓病、神経、産科/婦人科)
・世界の医療診断における人工知能(Ai)市場規模:エンドユーザー別(病院、画像診断センター、診断研究所、その他)
・世界の医療診断における人工知能(Ai)市場規模:地域別
・競争状況
・企業情報

“The global AI in medical diagnostics market is projected to reach USD 3,868 million by 2025 from USD 505 million in 2020, at a CAGR of 50.2% during the forecast period.”
Growth in this market is primarily driven by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and the growing number of cross-industry partnerships and collaborations.

“Software segment is expected to grow at the highest CAGR”
On the basis of component, the AI in medical diagnostics market is segmented into software and services. The services segment dominated this market in 2020, while the software segment is estimated to grow at a higher CAGR during the forecast period. Software solutions help healthcare providers gain a competitive edge despite the challenges of being short-staffed and facing increasing imaging scan volumes. This is a key factor driving the growth of the software segment.

“Hospitals to establish the largest market size of AI in medical diagnostics market”
Based on end user, the AI in medical diagnostics market is segmented into hospitals, diagnostic imaging centers, diagnostic laboratories, and other end users. The hospitals segment commanded the largest share of 64.1% of this market in 2019. The large share of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals, the growing inclination of hospitals toward the automation and digitization of radiology patient workflow, increasing adoption of minimally invasive procedures in hospitals to improve the quality of patient care, and the rising adoption of advanced imaging modalities to improve workflow efficiency.

“North America To Witness Significant Growth From 2020 To 2025”
The AI in medical diagnostics market has been segmented into four main regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share of 37.6%. However, the APAC market is projected to register the highest CAGR of 53.2% during the forecast period, primarily due to the growth strategies adopted by companies in emerging markets, improved medical diagnostic infrastructure, increasing geriatric population, rising prevalence of cancer, and the implementation of favorable government initiatives.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30% • By Designation: C-level – 27%, Director-level – 18%, and Others – 55% • By Region: North America – 40%, Europe – 20%, APAC – 30%, Rest of the World – 10%

Some of the prominent players operating in the AI in medical diagnostics market are Microsoft Corporation (US), NVIDIA (US), IBM (US), Intel (US), Siemens Healthineers (Germany), GE Healthcare (US), Digital Diagnostics (US), Xilinx (US), InformAI (US), Enlitic (US), Day Zero Diagnostics (US), Aidence (Netherlands), Butterfly Network, Inc. (US), Prognos (US), Zebra Medical Vision (Israel), Viz.ai (US), Quibin (Spain), Qure.ai (India), Therapixel (France), and HeartFlow (US).

Research Coverage
This report studies the AI in medical diagnosticsmarket based on component, end user, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 INCLUSIONS & EXCLUSIONS 24
1.3.1 MARKETS COVERED 25
FIGURE 1 AI IN MEDICAL DIAGNOSTICS MARKET SEGMENTATION 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 25
1.4 CURRENCY 26
1.5 LIMITATIONS 26
1.6 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.2 RESEARCH METHODOLOGY STEPS 27
FIGURE 2 RESEARCH METHODOLOGY: AI IN MEDICAL DIAGNOSTICS MARKET 27
FIGURE 3 RESEARCH DESIGN 28
2.2.1 SECONDARY DATA 28
2.2.1.1 Key data from secondary sources 29
2.2.2 PRIMARY DATA 30
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
FIGURE 5 PRIMARY SOURCES 31
2.2.2.1 Key data from primary sources 31
2.3 MARKET SIZE ESTIMATION METHODOLOGY 32
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 32
FIGURE 7 MARKET SIZE ESTIMATION 33
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 33
FIGURE 8 DATA TRIANGULATION METHODOLOGY 33
2.5 ASSUMPTIONS FOR THE STUDY 34
2.6 COVID-19-SPECIFIC ASSUMPTIONS 34
3 EXECUTIVE SUMMARY 35
FIGURE 9 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2020 VS. 2025 (USD MILLION) 35
FIGURE 10 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 36
FIGURE 11 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 36
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE AI IN MEDICAL DIAGNOSTICS MARKET 37
4 PREMIUM INSIGHTS 38
4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW 38
FIGURE 13 INFLUX OF LARGE AND COMPLEX DATASETS IN HEALTHCARE TO DRIVE MARKET GROWTH 38
4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2019) 39
FIGURE 14 IN VIVO DIAGNOSTIC APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019 39
4.3 AI IN MEDICAL DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2020 VS. 2025 39
FIGURE 15 IN VIVO DIAGNOSTIC APPLICATIONS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025 39
4.4 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 40
FIGURE 16 APAC MARKET TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
FIGURE 17 AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
5.1.1 DRIVERS 42
5.1.1.1 Influx of large and complex datasets 42
5.1.1.2 Growing number of cross-industry partnerships and collaborations 42
5.1.1.3 Increasing demand for AI tools in the medical imaging field and rising focus on reducing the workload of radiologists 43
5.1.1.4 Government initiative to increase the adoption of AI-based technologies 43
5.1.1.5 Growth in funding for AI-based start-ups 44
5.1.2 RESTRAINTS 45
5.1.2.1 Reluctance among medical practitioners to adopt AI-based technologies 45
5.1.2.2 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software 45
5.1.3 OPPORTUNITIES 46
5.1.3.1 Untapped emerging markets 46
5.1.3.2 Growing potential of AI-technology in imaging & diagnostics to fight COVID-19 46
5.1.3.3 Increasing focus on developing human-aware AI systems 47
5.1.4 CHALLENGES 47
5.1.4.1 Budgetary constraints 47
5.1.4.2 Lack of curated healthcare data 47
5.1.4.3 Concerns regarding data privacy 48
FIGURE 18 TYPES OF HEALTHCARE BREACHES REPORTED TO THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES (2018 TO 2020) 48
5.1.4.4 Lack of interoperability between AI solutions offered by different vendors 48

5.2 VALUE CHAIN ANALYSIS 49
FIGURE 19 AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 49
5.3 CASE STUDIES 49
5.3.1 FOCUS ON IMPROVING WORKFLOW EFFICACY AND REDUCING THE BURDEN ON RADIOLOGISTS 49
5.3.1.1 Use case 1: Reducing the burden on radiologists by developing and testing an AI model to read large ultrasound data 49
5.3.2 IMPROVED TRIAGE 50
5.3.2.1 Use case 2: Precision Driven Health developed ML model to help improve work triage of cardiologists (2019) 50
5.4 IMPACT OF COVID-19 ON THE AI IN MEDICAL DIAGNOSTICS MARKET 50
FIGURE 20 PRE- AND POST-COVID-19 IMPACT ANALYSIS 51
5.5 ECOSYSTEM COVERAGE 52
FIGURE 21 AI IN MEDICAL DIAGNOSTICS ECOSYSTEM 52
5.6 TECHNOLOGY ANALYSIS 52
TABLE 1 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS 52
5.7 REGULATIONS 53
5.7.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA) 53
5.7.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH) 53
5.7.3 CONSUMER PRIVACY PROTECTION ACT OF 2017 53
5.7.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015 53
5.7.5 FUTURE OF LIFE INSTITUTE’S ASILOMAR AI PRINCIPLES 54
5.7.6 THE EUROPEAN MEDICAL DEVICES REGULATION (EU) 2017/745 AND IN-VITRO DIAGNOSTIC MEDICAL DEVICES REGULATION (EU) 2017/746 IN COMBINATION WITH THE GENERAL DATA PROTECTION REGULATION 2016/679 54
5.7.7 THE CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA 54
5.8 PRICING ANALYSIS 54
6 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT 56
6.1 INTRODUCTION 57
TABLE 2 AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 57
6.1.1 SOFTWARE 57
6.1.1.1 Software segment to witness higher growth during the forecast period 57
TABLE 3 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY REGION,
2018–2025 (USD MILLION) 58
6.1.2 SERVICES 58
6.1.2.1 Services segment to account for a larger share of the market during the forecast period 58
TABLE 4 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 58
7 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,
BY APPLICATION 59
7.1 INTRODUCTION 60
TABLE 5 AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 60
7.2 IN VIVO DIAGNOSTICS 60
TABLE 6 AI IN IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 60
7.2.1 IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY 61
TABLE 7 AI IN IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 61
7.2.1.1 Radiology 61
7.2.1.1.1 AI-based diagnostic tools help ease the workflow of radiologists 61
TABLE 8 AI IN RADIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 62
7.2.1.2 Cardiology 62
7.2.1.2.1 Increased complexity of sudden cardiac diseases to drive market growth 62
TABLE 9 AI IN CARDIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 62
7.2.1.3 Neurology 63
7.2.1.3.1 Increased start-up funding to drive market growth 63
TABLE 10 AI IN NEUROLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 63
7.2.1.4 Obstetrics/gynecology 64
7.2.1.4.1 Rising use of minimally invasive techniques in gynecology procedures to drive market growth 64
TABLE 11 AI IN OBSTETRICS/GYNECOLOGY MARKET, BY REGION,
2018–2025 (USD MILLION) 64
7.2.1.5 Ophthalmology 64
7.2.1.5.1 Need for early detection and prevention of eye diseases driving the adoption of AI-based diagnostic tools 64
TABLE 12 AI IN OPHTHALMOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION) 65
7.2.1.6 Other specialties 65
TABLE 13 AI IN OTHER SPECIALTIES MARKET, BY REGION, 2018–2025 (USD MILLION) 65
7.2.2 IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY 66
TABLE 14 AI IN IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 66
7.2.2.1 Computed tomography 66
7.2.2.1.1 Need for efficient diagnosis will drive the adoption
of AI in computed tomography 66
TABLE 15 AI IN COMPUTED TOMOGRAPHY MARKET, BY REGION,
2018–2025 (USD MILLION) 67
7.2.2.2 X-ray 67
7.2.2.2.1 Companies such as NVIDIA, Intel, and Xilinx are developing AI-based tools exclusively in this space 67
TABLE 16 AI IN X-RAY MARKET, BY REGION, 2018–2025 (USD MILLION) 67
7.2.2.3 Magnetic resonance imaging 68
7.2.2.3.1 Increasing burden of brain-related disorders to drive the adoption of AI in magnetic resonance imaging 68
TABLE 17 AI IN MAGNETIC RESONANCE IMAGING MARKET, BY REGION,
2018–2025 (USD MILLION) 68
7.2.2.4 Ultrasound 68
7.2.2.4.1 Increasing prevalence of ovarian cancer and the need for its early diagnosis will drive market growth 68
TABLE 18 AI IN ULTRASOUND MARKET, BY REGION, 2018–2025 (USD MILLION) 69
7.2.2.5 Other modalities 69
TABLE 19 AI IN OTHER MODALITIES MARKET, BY REGION, 2018–2025 (USD MILLION) 69
7.3 IN VITRO DIAGNOSTICS 69
TABLE 20 AI IN IN VITRO DIAGNOSTIC APPLICATIONS MARKET, BY REGION,
2018–2025 (USD MILLION) 70
8 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER 71
8.1 INTRODUCTION 72
TABLE 21 AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 72
8.2 HOSPITALS 72
8.2.1 LARGE HOSPITALS HAVE BEEN THE EARLY ADOPTERS OF AI SOLUTIONS FOR DIAGNOSTIC IMAGING 72
TABLE 22 AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION,
2018–2025 (USD MILLION) 73
8.3 DIAGNOSTIC IMAGING CENTERS 73
8.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS IS CONTRIBUTING TO MARKET GROWTH 73
TABLE 23 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018–2025 (USD MILLION) 73
8.4 DIAGNOSTIC LABORATORIES 74
8.4.1 INCREASING SPECIMEN TEST VOLUMES AND WORKLOAD OF PATHOLOGISTS HAS BOOSTED THE MARKET GROWTH 74
TABLE 24 AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2018–2025 (USD MILLION) 74
8.5 OTHER END USERS 74
TABLE 25 AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION) 74
9 ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY REGION 75
9.1 INTRODUCTION 76
TABLE 26 AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION,
2018–2025 (USD MILLION) 76
9.2 NORTH AMERICA 76
FIGURE 22 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT 77
TABLE 27 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 28 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 78
TABLE 29 NORTH AMERICA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET,
BY SPECIALTY, 2018–2025 (USD MILLION) 78
TABLE 30 NORTH AMERICA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET,
BY MODALITY, 2018–2025 (USD MILLION) 78
TABLE 31 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2018–2025 (USD MILLION) 79
TABLE 32 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET,
BY END USER, 2018–2025 (USD MILLION) 79
9.2.1 US 79
9.2.1.1 Increasing volume of imaging procedures to drive market growth in the US 79
TABLE 33 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 80
TABLE 34 US: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 80
TABLE 35 US: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 81
TABLE 36 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 81
TABLE 37 US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 81
9.2.2 CANADA 82
9.2.2.1 Research grants and improved academics in the field of radiology to boost market growth in Canada 82
TABLE 38 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 82
TABLE 39 CANADA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018–2025 (USD MILLION) 82
TABLE 40 CANADA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018–2025 (USD MILLION) 83
TABLE 41 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 83
TABLE 42 CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 83
9.3 EUROPE 84
TABLE 43 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 84
TABLE 44 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 84
TABLE 45 EUROPE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018–2025 (USD MILLION) 85
TABLE 46 EUROPE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 85
TABLE 47 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 85
TABLE 48 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 86
9.3.1 GERMANY 86
9.3.1.1 Government initiatives to expedite AI development in Germany 86
TABLE 49 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 86
TABLE 50 GERMANY: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018–2025 (USD MILLION) 87
TABLE 51 GERMANY: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY, 2018–2025 (USD MILLION) 87
TABLE 52 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 87
TABLE 53 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 88
9.3.2 UK 88
9.3.2.1 Increasing number of radiography procedures to drive market growth in the UK 88
TABLE 54 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 88
TABLE 55 UK: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 89
TABLE 56 UK: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 89
TABLE 57 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 89
TABLE 58 UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 90
9.3.3 FRANCE 90
9.3.3.1 Availability of funding for companies to enhance AI research in medical imaging 90
TABLE 59 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 90
TABLE 60 FRANCE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018–2025 (USD MILLION) 91
TABLE 61 FRANCE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 91
TABLE 62 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 91
TABLE 63 FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 92
9.3.4 REST OF EUROPE 92
TABLE 64 ROE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 92
TABLE 65 ROE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 93
TABLE 66 ROE: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 93
TABLE 67 ROE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 94
TABLE 68 ROE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 94
9.4 ASIA PACIFIC 95
FIGURE 23 APAC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT 95
TABLE 69 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 96
TABLE 70 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 96
TABLE 71 APAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 96
TABLE 72 APAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 97
TABLE 73 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 97
TABLE 74 APAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 97
9.4.1 CHINA 98
9.4.1.1 China dominated the APAC market in 2019 98
TABLE 75 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 98
TABLE 76 CHINA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 98
TABLE 77 CHINA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 99
TABLE 78 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 99
TABLE 79 CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 99
9.4.2 JAPAN 100
9.4.2.1 Presence of a strong infrastructure to drive the adoption of AI in Japan 100
TABLE 80 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 100
TABLE 81 JAPAN: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 100
TABLE 82 JAPAN: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 101
TABLE 83 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 101
TABLE 84 JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 101
9.4.3 INDIA 102
9.4.3.1 Favorable government initiatives to boost market growth in India 102
TABLE 85 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 102
TABLE 86 INDIA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 103
TABLE 87 INDIA: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 103
TABLE 88 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 103
TABLE 89 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 104
9.4.4 REST OF ASIA PACIFIC 104
TABLE 90 ROAPAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 104
TABLE 91 ROAPAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY, 2018–2025 (USD MILLION) 105
TABLE 92 ROAPAC: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 105
TABLE 93 ROAPAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 105
TABLE 94 ROAPAC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 106
9.5 REST OF THE WORLD 106
TABLE 95 ROW: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 106
TABLE 96 ROW: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY,
2018–2025 (USD MILLION) 107
TABLE 97 ROW: IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY,
2018–2025 (USD MILLION) 107
TABLE 98 ROW: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT,
2018–2025 (USD MILLION) 107
TABLE 99 ROW: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 108
10 COMPETITIVE LANDSCAPE 109
10.1 OVERVIEW 109
FIGURE 24 MARKET EVALUATION FRAMEWORK, 2018–2021 109
10.2 KEY PLAYER STRATEGIES 110
10.3 RANKING OF PLAYERS, 2019 110
FIGURE 25 RANKING OF KEY COMPANIES IN THE AI IN MEDICAL DIAGNOSTICS MARKET (2019) 110
10.4 COMPETITIVE LEADERSHIP MAPPING 111
10.4.1 STARS 112
10.4.2 EMERGING LEADERS 112
10.4.3 PERVASIVE PLAYERS 112
10.4.4 PARTICIPANTS 112
FIGURE 26 AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 113
10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) 114
10.5.1 PROGRESSIVE COMPANIES 114
10.5.2 DYNAMIC COMPANIES 114
10.5.3 RESPONSIVE COMPANIES 114
10.5.4 STARTING BLOCKS 114
FIGURE 27 AI IN MEDICAL DIAGNOSTICS MARKET (START-UPS): COMPETITIVE LEADERSHIP MAPPING (2019) 115
10.6 COMPANY PRODUCT FOOTPRINT 116
TABLE 100 FOOTPRINT OF COMPANIES 116
TABLE 101 APPLICATION FOOTPRINT OF COMPANIES 116
TABLE 102 REGIONAL FOOTPRINT OF COMPANIES 117
10.7 COMPETITIVE SCENARIO 117
TABLE 103 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES, 2018–2021 117
TABLE 104 AI IN MEDICAL DIAGNOSTICS MARKET: DEALS, 2018–2021 118
TABLE 105 AI IN MEDICAL DIAGNOSTICS MARKET: OTHER DEVELOPMENTS, 2018–2021 119
11 COMPANY PROFILES 120
11.1 MAJOR PLAYERS 120
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 MICROSOFT CORPORATION 120
TABLE 106 MICROSOFT CORPORATION: BUSINESS OVERVIEW 120
FIGURE 28 MICROSOFT CORPORATION: COMPANY SNAPSHOT 121
TABLE 107 MICROSOFT CORPORATION: PRODUCTS OFFERED 121
11.1.2 NVIDIA 123
TABLE 108 NVIDIA: BUSINESS OVERVIEW 123
FIGURE 29 NVIDIA: COMPANY SNAPSHOT 124
TABLE 109 NVIDIA: PRODUCTS OFFERED 124
11.1.3 IBM 127
TABLE 110 IBM: BUSINESS OVERVIEW 127
FIGURE 30 IBM: COMPANY SNAPSHOT 128
TABLE 111 IBM: PRODUCTS OFFERED 128
11.1.4 INTEL 129
TABLE 112 INTEL: BUSINESS OVERVIEW 129
FIGURE 31 INTEL: COMPANY SNAPSHOT 130
TABLE 113 INTEL: PRODUCTS OFFERED 130
11.1.5 GOOGLE (SUBSIDIARY OF ALPHABET, INC.) 133
TABLE 114 GOOGLE: BUSINESS OVERVIEW 133
FIGURE 32 GOOGLE: COMPANY SNAPSHOT 134
TABLE 115 GOOGLE: PRODUCTS OFFERED 134
11.1.6 SIEMENS HEALTHINEERS 136
TABLE 116 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 136
FIGURE 33 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT 136
TABLE 117 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 137
11.1.7 GE HEALTHCARE 139
TABLE 118 GE HEALTHCARE: BUSINESS OVERVIEW 139
FIGURE 34 GE HEALTHCARE: COMPANY SNAPSHOT 140
TABLE 119 GE HEALTHCARE: PRODUCTS OFFERED 140
11.2 OTHER PLAYERS 143
11.2.1 DIGITAL DIAGNOSTICS (FORMERLY KNOWN AS IDX) 143
TABLE 120 DIGITAL DIAGNOSTICS: BUSINESS OVERVIEW 143
TABLE 121 DIGITAL DIAGNOSTICS: PRODUCTS OFFERED 143
11.2.2 XILINX 145
TABLE 122 XILINX: BUSINESS OVERVIEW 145
FIGURE 35 XILINX: COMPANY SNAPSHOT 145
TABLE 123 XILINX: PRODUCTS OFFERED 146
11.2.3 INFORMAI 148
TABLE 124 INFORMAI: BUSINESS OVERVIEW 148
TABLE 125 INFROMAI: PRODUCTS OFFERED 148
11.2.4 HEARTFLOW 149
TABLE 126 HEARTFLOW: BUSINESS OVERVIEW 149
TABLE 127 HEARTFLOW: PRODUCTS OFFERED 149
11.2.5 ENLITIC 151
TABLE 128 ENLITIC: BUSINESS OVERVIEW 151
TABLE 129 ENLITIC: PRODUCTS OFFERED 151
11.2.6 DAY ZERO DIAGNOSTICS 153
TABLE 130 DAY ZERO DIAGNOSTICS: BUSINESS OVERVIEW 153
11.2.6.2 Products offered 153
TABLE 131 DAY ZERO DIAGNOSTICS: PRODUCTS OFFERED 153
11.2.7 AIDENCE 154
TABLE 132 AIDENCE: BUSINESS OVERVIEW 154
TABLE 133 AIDENCE: PRODUCTS OFFERED 154
11.2.8 BUTTERFLY NETWORK, INC. 156
TABLE 134 BUTTERFLY NETWORK: BUSINESS OVERVIEW 156
TABLE 135 BUTTERFLY NETWORK: PRODUCTS OFFERED 156
11.2.9 PROGNOS 158
TABLE 136 PROGNOS: BUSINESS OVERVIEW 158
TABLE 137 PROGNOS: PRODUCTS OFFERED 158
11.2.10 ZEBRA MEDICAL VISION 159
TABLE 138 ZEBRA MEDICAL VISION: BUSINESS OVERVIEW 159
TABLE 139 ZEBRA MEDICAL VISION: PRODUCTS OFFERED 159
11.2.11 VIZ.AI 161
TABLE 140 VIZ.AI: BUSINESS OVERVIEW 161
TABLE 141 VIZ.AI: PRODUCTS OFFERED 161
11.2.12 QUIBIM 162
TABLE 142 QUIBIM: BUSINESS OVERVIEW 162
TABLE 143 QUIBIM: PRODUCTS OFFERED 162
11.2.13 QURE.AI 164
TABLE 144 QURE.AI: BUSINESS OVERVIEW 164
TABLE 145 QURE.AI: PRODUCTS OFFERED 164
11.2.14 THERAPIXEL 165
TABLE 146 THERAPIXEL: BUSINESS OVERVIEW 165
TABLE 147 THERAPIXEL: PRODUCTS OFFERED 165
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 166
12.1 DISCUSSION GUIDE 166
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 169
12.3 AVAILABLE CUSTOMIZATIONS 171
12.4 RELATED REPORTS 171
12.5 AUTHOR DETAILS 172



★調査レポート[世界の医療診断における人工知能(Ai)市場予測:コンポーネント別、用途別、エンドユーザー別] ( Artificial Intelligence (Ai) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025 / HIT7875) 販売に関する免責事項
[世界の医療診断における人工知能(Ai)市場予測:コンポーネント別、用途別、エンドユーザー別] ( Artificial Intelligence (Ai) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, OBGY,MRI, CT, Ultrasound, IVD), End User (Hospital, Diagnostic Laboratory, Diagnostic Imaging Center)- Global Forecast to 2025 / HIT7875) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆